The influence of growth on development outcome in extremely low birthweight infants at 2 years of age

Autor: Yvonne R. Burns, David I. Tudehope, Michael O'Callaghan, Y. Rogers, Peter H. Gray, Heather Mohay, JM Connors

Publikováno v: Journal of Paediatrics and Child Health. 35:37-41

Objective: To determine if weight

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c0c465b8508b644a56c71adb77f1d3
https://doi.org/10.1046/j.1440-1754.1999.00309.x

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

Autor: Stephen H. Nantel, J D Shepherd, RN Fairey, D. E. Reece, JM Connors, Hans G. Klingemann, JJ Spinelli, Heather J. Sutherland, M. J. Barnett, S O'Reilly

Publikováno v: Blood. 83:1193-1199

The optimal timing in which to use intensive chemotherapy and autologous bone marrow transplantation (BMT) in Hodgkin's disease (HD) is uncertain. In 1985, we initiated a program in which this modality was used as the initial salvage therapy in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6de0a42e95c8cdcf518667bc0208aea7
https://doi.org/10.1182/blood.v83.5.1193.1193

Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988

Autor: A Lohri, M Barnett, RN Fairey, SE O'Reilly, GL Phillips, D Reece, N Voss, JM Connors

Publikováno v: Blood. 77:2292-2298

The outcome of treatment for a first relapse of Hodgkin's disease after primary chemotherapy was analyzed in 80 patients. They were divided into four groups: group 1 (n = 24) had initially been treated with three cycles of (mechlorethamine, vincristi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c52af3f512d56185a7bf514629db8ab5
https://doi.org/10.1182/blood.v77.10.2292.bloodjournal77102292

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma

Autor: Ah, Banham, Jm, Connors, Pj, Brown, Jl, Cordell, Ott G, Sreenivasan G, Pedro Farinha, Horsman DE, Rd, Gascoyne

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d9462e2d3e4b19fee7fce8677875326
http://europepmc.org/abstract/med/15709173

Troubleshooting heparin resistance.

Autor: Maier CL; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Atlanta, GA., Connors JM; Department of Medicine, Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Levy JH; Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC.

Publikováno v: Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 186-191.